Lack of CNS penetration of docetaxel in a patient with leptomeningeal carcinomatosis.
Herrington
J D
JD
Di Nunno
L
L
Rinehart
J J
JJ
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics*; D001099:Arachnoid; D001812:Blood-Brain Barrier; D001943:Breast Neoplasms / Q000473:pathology; D002277:Carcinoma / Q000134:cerebrospinal fluid* / Q000556:secondary; D018270:Carcinoma, Ductal, Breast / Q000134:cerebrospinal fluid / Q000556:secondary; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008577:Meningeal Neoplasms / Q000134:cerebrospinal fluid* / Q000556:secondary; D017239:Paclitaxel / Q000031:analogs & derivatives* / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel